CN1176700C - Medicine for treating damp arthralgia - Google Patents

Medicine for treating damp arthralgia Download PDF

Info

Publication number
CN1176700C
CN1176700C CNB021279535A CN02127953A CN1176700C CN 1176700 C CN1176700 C CN 1176700C CN B021279535 A CNB021279535 A CN B021279535A CN 02127953 A CN02127953 A CN 02127953A CN 1176700 C CN1176700 C CN 1176700C
Authority
CN
China
Prior art keywords
medicine
portions
wind
present
cold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB021279535A
Other languages
Chinese (zh)
Other versions
CN1429599A (en
Inventor
赵新环
伍胜利
刘正月
朱召留
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guoyaojituan Tongjitang Guizhou Pharmaceutical Co ltd
Original Assignee
GUIZHOU LONGLIFE PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4745867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1176700(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by GUIZHOU LONGLIFE PHARMACEUTICAL CO Ltd filed Critical GUIZHOU LONGLIFE PHARMACEUTICAL CO Ltd
Priority to CNB021279535A priority Critical patent/CN1176700C/en
Publication of CN1429599A publication Critical patent/CN1429599A/en
Application granted granted Critical
Publication of CN1176700C publication Critical patent/CN1176700C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a medicine for treating arthromyodynia, which is a Chinese patent medicine prepared from the raw materials in the following weight proportion: 60 portions of orientvine stem, 40 portions of Heiguteng and 34 portions of starflowerlike loosestrife root by a general preparation technology. The present invention provides a medicine prepared according to the theory of Miao medicine and a new formula. The medicine has the functions for dispelling wind, eliminating dampness, activating meridians and alleviating pain, has the characteristics of simple manufacture, low cost and favorable therapeutic effects, and has peculiar therapeutic effects on wind-cold-dampness arthralgia and pain of the shoulders, arms, waists and legs caused by the wind-cold-dampness arthralgia.

Description

A kind of medicine for the treatment of arthromyodynia
Technical field: the present invention relates to a kind of Chinese medicine preparation, particularly a kind of Chinese patent medicine for the treatment of arthromyodynia.
Background technology: arthromyodynia (claiming rheumatism again) belongs to commonly encountered diseases and frequently-occurring disease.At present, it is more to treat rheumatismal medicine, and various medicines have the characteristics of oneself separately, but also have certain deficiency simultaneously, so various medicine can and be deposited on market, and is accepted by the patient.
Summary of the invention: the objective of the invention is to, a kind of medicine of new treatment arthromyodynia is provided.It is a kind of medicine of making by Seedling medicine theory and new prescription, expelling wind and removing dampness is arranged, the function of removing obstruction in the collateral to relieve pain.The shoulder arm lumbago and skelalgia that causes for anemofrigid-damp arthralgia and Yin Qi has unique therapeutic effect.
Technical scheme of the present invention.The medicine of treatment arthromyodynia, it is with following materials of weight proportions, 60 parts of Caulis Sinomeniis, 40 parts of Heiguteng exracts, 34 parts of Lysimachia trientaloides Hemsl.s, the Chinese patent medicine that is prepared into of preparation process routinely.
Compared with the prior art, the present invention is a kind of medicine of making by Seedling medicine theory and new prescription.It adopts comparatively in the localities Chinese medicinal herbses of seeing as raw material more, and is with low cost.Expelling wind and removing dampness is arranged, the function of removing obstruction in the collateral to relieve pain.Have the making of being easy to, cost is lower, the characteristics that therapeutic effect is good.The shoulder arm lumbago and skelalgia that causes for anemofrigid-damp arthralgia and Yin Qi has unique therapeutic effect.
The specific embodiment:
Embodiment 1.Get Caulis Sinomenii 60Kg, Heiguteng exract 40Kg, Lysimachia trientaloides Hemsl. 34Kg as raw material.Caulis Sinomenii with 1/9 weight is ground into fine powder, as the A product.Remaining Caulis Sinomenii mixes decoction with Heiguteng exract, Lysimachia trientaloides Hemsl.; For the first time add 6 times of water gagings, soaked 2 hours, decocted 2.5 hours; For the second time add 5 times of water gagings, decocted 2 hours; Add 4 times of water gagings for the third time, decocted 1.5 hours; Collecting decoction filters, and it is 1.25~1.30 clear paste that filtrate is condensed into relative density.The A product are added the clear paste mixing, at drying under reduced pressure below 80 ℃, be ground into fine powder, add an amount of starch, make granule, drying incapsulates, and capsule gets product.By every 0.3g, every day 3 times, take for each 3.Two weeks were a course of treatment.
The present invention also routinely preparation process make other dosage forms such as tablet, electuary, syrup.

Claims (1)

1, a kind of medicine for the treatment of arthromyodynia is characterized in that, it is with following materials of weight proportions, 60 parts of Caulis Sinomeniis, 40 parts of Heiguteng exracts, 34 parts of Lysimachia trientaloides Hemsl.s, the Chinese patent medicine that is prepared into of preparation process routinely.
CNB021279535A 2002-12-02 2002-12-02 Medicine for treating damp arthralgia Expired - Lifetime CN1176700C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021279535A CN1176700C (en) 2002-12-02 2002-12-02 Medicine for treating damp arthralgia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021279535A CN1176700C (en) 2002-12-02 2002-12-02 Medicine for treating damp arthralgia

Publications (2)

Publication Number Publication Date
CN1429599A CN1429599A (en) 2003-07-16
CN1176700C true CN1176700C (en) 2004-11-24

Family

ID=4745867

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021279535A Expired - Lifetime CN1176700C (en) 2002-12-02 2002-12-02 Medicine for treating damp arthralgia

Country Status (1)

Country Link
CN (1) CN1176700C (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1305489C (en) * 2005-08-10 2007-03-21 贵州老来福药业有限公司 Rheumatism treating plaster with 'Miao' ethnic drug Heiguteng and preparation process thereof
CN102058671B (en) * 2010-04-08 2012-07-04 姜红成 Traditional Chinese medicine for expelling wind, removing dampness, dredging channel and stopping pain and preparation method thereof
CN102579601A (en) * 2011-04-06 2012-07-18 四川师范大学 Medicinal composition for treating rheumatoid arthritis, and preparation method and application thereof
CN104524220A (en) * 2015-01-09 2015-04-22 杨茹芹 Traditional Chinese medicine composition for treating qi depression blood stagnation type scleroderma

Also Published As

Publication number Publication date
CN1429599A (en) 2003-07-16

Similar Documents

Publication Publication Date Title
CN101966271B (en) Chinese medicinal decoction for treating hypertension
CN103656238A (en) Traditional Chinese medicine composition for treating rheumatic bone diseases
CN101152378B (en) Externally used traditional Chinese medicine preparation for diminishing the inflammation and reducing the pain
CN101129826B (en) Health pillow with Chinese medicine
CN1176700C (en) Medicine for treating damp arthralgia
KR101681890B1 (en) The herbal mixture extract as an active ingredient for prevention and treatment of osteoporosis composition and its manufacture method
CN105726576A (en) Tablet used for treating angina in slow-release stage and preparation method thereof
CN100450494C (en) Medicinal use of Aralia continentalis kitag
CN102139032B (en) Traditional Chinese medicine for treating intervertebral disc protrusion, hyperosteogeny and rheumatoid disease
CN103751648B (en) For the goods of cyclomastopathy patient
CN104208385A (en) Chinese medicinal drug for treating phlegm-dampness stagnation syndrome type tinnitus cerebri
CN101274000B (en) Medicine use of herb aralia elata seem
CN102716449A (en) Chinese patent drug and traditional Chinese medicine decoction capable of treating excessive-cold type stomachache effectively
CN100393349C (en) Analgetic
CN101259196B (en) Chinese medicinal composition for treating gastric ulcer
CN106038659A (en) External-applied traditional Chinese medicine powder for healing scalds and burns without leaving scars and preparation method and application thereof
CN1157220C (en) Medicine for treating intestinal disease
CN104547352A (en) Pharmaceutical composition for treating facioplegia
CN1207037C (en) Dampness-removing embolism-dissolving medicine
CN104306585A (en) Traditional Chinese medicine combination for curing prostatitis, and preparation method and application thereof
CN103933210A (en) Abalone-ingredient-containing traditional Chinese medicine preparation for treating epilepsia
CN103142899A (en) Preparation method of drug for treating spondyloepiphyseal dysplasia
CN103285339A (en) External medicine for treating bone pain disease
CN102836217A (en) Unique traditional Chinese medicine traumatic wine
CN102018865A (en) Chinese medicinal composition for treating deaf

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: 550009 No. 296 Southwest Ring Road, Xiaohe District, Guizhou, Guiyang

Patentee after: Guizhou Longlife Pharmaceutical Co.,Ltd.

Address before: 550025 south section of Huaxi Road, Guiyang, Guizhou

Patentee before: Guizhou Longlife Pharmaceutical Co.,Ltd.

C56 Change in the name or address of the patentee

Owner name: LONGLIFE (GUIZHOU) PHARMACEUTICAL CO., LTD. OF SIN

Free format text: FORMER NAME: GUIZHOU LAOLAIFU MEDICINE CO., LTD.

CP01 Change in the name or title of a patent holder

Address after: 550009 No. 296 Southwest Ring Road, Xiaohe District, Guizhou, Guiyang

Patentee after: SINOPHARM LONGLIFE (GUIZHOU) PHARMACEUTICAL Co.,Ltd.

Address before: 550009 No. 296 Southwest Ring Road, Xiaohe District, Guizhou, Guiyang

Patentee before: Guizhou Longlife Pharmaceutical Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20171121

Address after: No. 99, Guiyang economic and Technological Development Zone, Guizhou Province

Patentee after: GUOYAOJITUAN TONGJITANG (GUIZHOU) PHARMACEUTICAL CO.,LTD.

Address before: 550009 No. 296 Southwest Ring Road, Xiaohe District, Guizhou, Guiyang

Patentee before: SINOPHARM LONGLIFE (GUIZHOU) PHARMACEUTICAL Co.,Ltd.

DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: SINOPHARM LONGLIFE (GUIZHOU) PHARMACEUTICAL Co.,Ltd.

Document name: Notification of Passing Examination on Formalities

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20041124